doranidazole has been researched along with ak 2123 in 1 studies
| Studies (doranidazole) | Trials (doranidazole) | Recent Studies (post-2010) (doranidazole) | Studies (ak 2123) | Trials (ak 2123) | Recent Studies (post-2010) (ak 2123) |
|---|---|---|---|---|---|
| 30 | 4 | 10 | 52 | 8 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shibamoto, Y | 1 |
1 review(s) available for doranidazole and ak 2123
| Article | Year |
|---|---|
[Contribution of radiation biology to the development of radiation therapy].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Humans; Imidazoles; Lung Neoplasms; Neoplasms; Nimorazole; Radiation-Sensitizing Agents; Triazoles | 1999 |